Work

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

Year: 2021
Type: review
Abstract: c-Myc is a transcription factor that is constitutively and aberrantly expressed in over 70% of human cancers. Its direct inhibition has been shown to trigger rapid tumor regression in mice with only mild and fully reversible side effects, suggesting this to be a viable therapeutic strategy. Here we reassess the challenges of directly targeting c-Myc, evaluate lessons learned from current inhibitors, and explore how future strategies such as miniaturisation of Omomyc and targeting E-box binding could facilitate translation of c-Myc inhibitors into the clinic.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,480
OpenAlex ID: W3109004530
FWCI: 8.847
Cites: 177
Cited by: 430
Related to: 10